Introduction: Why Site-Specificity Is the Defining Challenge in Glycosylation Analysis of Biosimilars Glycosylation Analysis of Biosimilars is a critical step […]
Introduction to Post-Translational Modifications (PTMs) in Biosimilars Post-Translational Modifications (PTMs) in Biosimilars play a central role in defining the safety,
Introduction: The Analytical Burden of Sequence Confirmation in Biosimilars Peptide Mapping in Biosimilars plays a critical role during development, but
Peptide Mapping in Biosimilar Development: Sequence Confirmation and Variant Detection Read More »
Introduction: The accurate confirmation of molecular identity and the detailed characterization of heterogeneity are among the most essential analytical steps
Intact Mass Analysis for Biosimilars: Confirming Molecular Identity and Heterogeneity Read More »
Introduction: Why LC-MS/MS Is Central to Proving Biosimilarity Using LC-MS To Prove Biosimilarity Using LC-MS, companies must meet strict scientific
Introduction: Reverse Engineering Risperidone PLGA Microspheres is a critical approach in modern pharmaceutical development, particularly for long-acting injectable formulations. By
The Strategic Imperative of Biosimilar Characterization Using Mass Spectrometry Biosimilar Characterization Using Mass Spectrometry is a critical scientific approach used
Summary: Dulaglutide Sameness Study is a comprehensive analytical comparison demonstrating that a proposed generic dulaglutide product is structurally and chemically
Introduction: Exenatide PLGA Microsphere Characterization plays a pivotal role in the development of long-acting injectable formulations, particularly for GLP-1 analogs
Introduction: Nitrosamine Testing for Rifabutin is an essential safety and regulatory process used to detect and measure harmful impurities, including
Nitrosamine Testing for Rifabutin API and Finished Products Read More »
